Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Toripalimab or Placebo Combined With Chemotherapy in Treatment-naive Advanced NSCLC [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating toripalimab with chemotherapy versus placebo with chemotherapy in treatment-naive advanced non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Treatment-naive Advanced Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED